McGill University researchers, in collaboration with colleagues in Israel and Ireland, have developed AI technology that can detect patterns in gut bacteria to identify complex regional pain syndrome (CRPS) with remarkable accuracy, potentially transforming how CRPS is diagnosed and treated.
The research identified significant differences between the gut bacteria of CRPS patients and pain-free individuals.
Read the full announcement, and learn more about the study, on the McGill Newsroom.
RSDSA has contacted the researchers to learn more about future trials/studies. We have also invited them to speak with the community about the findings. Stay tuned for more details!
